Vivos Therapeutics
VVOS
VVOS
16 hedge funds and large institutions have $647K invested in Vivos Therapeutics in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
79% less capital invested
Capital invested by funds: $3.12M → $647K (-$2.47M)
Holders
16
Holding in Top 10
–
Calls
$18K
Puts
–
Top Buyers
| 1 | +$225K | |
| 2 | +$72K | |
| 3 | +$3.16K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$386 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$53 |
Top Sellers
| 1 | -$623K | |
| 2 | -$18.6K | |
| 3 | -$773 | |
| 4 |
BlackRock
New York
|
-$522 |
| 5 |
Morgan Stanley
New York
|
-$324 |